These results not only validate the Cri-dots as novel vehicle for targeting CRISPR-cas gene editing strategy but also propose papG as a good candidate for anti-virulence therapy against UPEC involving ascending UTIs and pyelonephritis. The gene discussed is PAPOLG; the disease is pyelonephritis.